Literature DB >> 31659726

Growth and Nutrition in Cystic Fibrosis.

Jefferson N Brownell1,2, Hillary Bashaw1,2, Virginia A Stallings1,2.   

Abstract

Optimal nutrition support has been integral in the management of cystic fibrosis (CF) since the disease was initially described. Nutritional status has a clear relationship with disease outcomes, and malnutrition in CF is typically a result of chronic negative energy balance secondary to malabsorption. As the mechanisms underlying the pathology of CF and its implications on nutrient absorption and energy expenditure have been elucidated, nutrition support has become increasingly sophisticated. Comprehensive nutrition monitoring and treatment guidelines from professional and advocacy organizations have unified the approach to nutrition optimization around the world. Newborn screening allows for early nutrition intervention and improvement in short- and long-term growth and other clinical outcomes. The nutrition support goal in CF care includes achieving optimal nutritional status to support growth and pubertal development in children, maintenance of optimal nutritional status in adult life, and optimizing fat soluble vitamin and essential fatty acid status. The mainstay of this approach is a high calorie, high-fat diet, exceeding age, and sex energy intake recommendations for healthy individuals. For patients with exocrine pancreatic insufficiency, enzyme replacement therapy is required to improve fat and calorie absorption. Enzyme dosing varies by age and dietary fat intake. Multiple potential impediments to absorption, including decreased motility, altered gut luminal bile salt and microbiota composition, and enteric inflammation must be considered. Fat soluble vitamin supplementation is required in patients with pancreatic insufficiency. In this report, nutrition support across the age and disease spectrum is discussed, with a focus on the relationships among nutritional status, growth, and disease outcomes. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Year:  2019        PMID: 31659726     DOI: 10.1055/s-0039-1696726

Source DB:  PubMed          Journal:  Semin Respir Crit Care Med        ISSN: 1069-3424            Impact factor:   3.119


  8 in total

Review 1.  Increasing life expectancy in cystic fibrosis: Advances and challenges.

Authors:  Kimberly A McBennett; Pamela B Davis; Michael W Konstan
Journal:  Pediatr Pulmonol       Date:  2021-11-11

2.  Magnesium Status and Calcium/Magnesium Ratios in a Series of Cystic Fibrosis Patients.

Authors:  Marlene Fabiola Escobedo-Monge; Enrique Barrado; Joaquín Parodi-Román; María Antonieta Escobedo-Monge; Marianela Marcos-Temprano; José Manuel Marugán-Miguelsanz
Journal:  Nutrients       Date:  2022-04-25       Impact factor: 6.706

Review 3.  Role of inflammation and oxidative stress in tissue damage associated with cystic fibrosis: CAPE as a future therapeutic strategy.

Authors:  Victor Emanuel Miranda Soares; Thiago Inácio Teixeira do Carmo; Fernanda Dos Anjos; Jonatha Wruck; Sarah Franco Vieira de Oliveira Maciel; Margarete Dulce Bagatini; Débora Tavares de Resende E Silva
Journal:  Mol Cell Biochem       Date:  2021-09-16       Impact factor: 3.396

4.  Adherence to Dietary Recommendations, Nutrient Intake Adequacy and Diet Quality among Pediatric Cystic Fibrosis Patients: Results from the GreeCF Study.

Authors:  Dimitrios Poulimeneas; Maria G Grammatikopoulou; Panagiota Devetzi; Argyri Petrocheilou; Athanasios G Kaditis; Theodora Papamitsou; Stavros E Doudounakis; Tonia Vassilakou
Journal:  Nutrients       Date:  2020-10-13       Impact factor: 5.717

5.  Triage for Malnutrition Risk among Pediatric and Adolescent Outpatients with Cystic Fibrosis, Using a Disease-Specific Tool.

Authors:  Dimitrios Poulimeneas; Maria G Grammatikopoulou; Argyri Petrocheilou; Athanasios G Kaditis; Tonia Vassilakou
Journal:  Children (Basel)       Date:  2020-12-04

6.  Disease-related blood-based differential methylation in cystic fibrosis and its representation in lung cancer revealed a regulatory locus in PKP3 in lung epithelial cells.

Authors:  Esther Schamschula; Angelika Lahnsteiner; Yassen Assenov; Wolfgang Hagmann; Nadja Zaborsky; Markus Wiederstein; Anna Strobl; Frauke Stanke; Thomas Muley; Christoph Plass; Burkhard Tümmler; Angela Risch
Journal:  Epigenetics       Date:  2021-08-20       Impact factor: 4.861

Review 7.  Update on the management of vitamins and minerals in cystic fibrosis.

Authors:  Senthilkumar Sankararaman; Sara J Hendrix; Terri Schindler
Journal:  Nutr Clin Pract       Date:  2022-08-23       Impact factor: 3.204

Review 8.  Pancreatic complications in children with cystic fibrosis.

Authors:  Zachary M Sellers
Journal:  Curr Opin Pediatr       Date:  2020-10       Impact factor: 2.893

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.